Concepedia

David Woolley

DW

Statistics

Publications

16

Citations

1.3K

H-Index

16

Active since

1988

Affiliations

Center for Drug Evaluation and Research(Current)

Sanofi (Germany)

National One Call (United Kingdom)

UCB Pharma (Belgium)

Gilead Sciences (United States)

David Woolley is an author at Center for Drug Evaluation and Research specializing in pharmacy, toxicology, and in silico toxicity prediction.

Publications per year

1988–2022

16

Publications

16

Neurofascin as a novel target for autoantibody-mediated axonal injury

Emily K. Mathey, Maria K. Storch, Kieran R. Williams et al. · The Journal of Experimental Medicine · 2007 · 382 citations · Full text

Life Sciences, Neurology, Neuroscience +17

In silico toxicology protocols

Glenn J. Myatt, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2018 · 241 citations · Full text

Pharmacy, Toxicology, Developmental Toxicology +11

Catabolism of Intact Type VI Collagen Microfibrils: Susceptibility to Degradation by Serine Proteinases

C M Kielty, Marjorie B. Lees, C. Adrian Shuttleworth et al. · Biochemical and Biophysical Research Communications · 1993 · 139 citations

Life Sciences, Biochemistry, Pathology +14

Evidence for a semisolid phase state of aerosols and droplets relevant to the airborne and surface survival of pathogens

Erik Huynh, Anna Olinger, David Woolley et al. · Proceedings of the National Academy of Sciences · 2022 · 103 citations · Full text

Natural Sciences, Infectious Diseases, Air Quality Management +16

Genetic toxicology in silico protocol

Catrin Hasselgren, Ernst Ahlberg, Yumi Akahori et al. · Regulatory Toxicology and Pharmacology · 2019 · 82 citations · Full text

Pharmacy, Bioinformatics, Toxicology +13

1–5 of 16